Peri-Implant Surgical Treatment Downregulates the Expression of sTREM-1 and MMP-8 in Patients with Peri-Implantitis: A Prospective Study.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
18 03 2022
Historique:
received: 25 01 2022
revised: 15 03 2022
accepted: 15 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 19 4 2022
Statut: epublish

Résumé

sTREM-1 and its ligand PGLYRP1 play an essential role in the inflammatory process around teeth and implants. In this study, we aimed to evaluate the impact of peri-implant treatment on the salivary levels of the sTREM-1/PGLYRP-1/MMP-8 axis after 3 months. A total of 42 participants (with a mean age of 61 years old ± 7.3) were enrolled in this longitudinal study, 24 having peri-implant mucositis (MU) and 18 having peri-implantitis (PI). Clinical peri-implant parameters, such as probing pocket depth (PPD), % of plaque, and bleeding on probing (BOP), and the whole unstimulated saliva samples were evaluated at baseline and 3 months after treatment. The MU group received nonsurgical peri-implant treatment, while the PI group received open-flap procedures. The levels of sTREM-1, PGLYRP-1, MMP-8, and TIMP-1 were analyzed using enzyme-linked immunosorbent assays. BOP, plaque levels, and PPD significantly reduced after treatment in both groups. A significant decrease in the salivary levels of sTREM-1, MMP-8, and TIMP-1 in the PI group and PGLYRP1 and TIMP-1 in the MU group were observed. Salivary levels of sTREM-1 were significantly reduced in patients with PI but not with MU. Additionally, peri-implant treatment had a significantly higher impact on MMP-8 reduction in patients with PI than in those with MU.

Identifiants

pubmed: 35329310
pii: ijerph19063627
doi: 10.3390/ijerph19063627
pmc: PMC8955840
pii:
doi:

Substances chimiques

TIMP1 protein, human 0
TREM1 protein, human 0
Tissue Inhibitor of Metalloproteinase-1 0
Triggering Receptor Expressed on Myeloid Cells-1 0
MMP8 protein, human EC 3.4.24.34
Matrix Metalloproteinase 8 EC 3.4.24.34

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Periodontol 2000. 2016 Feb;70(1):38-52
pubmed: 26662481
J Clin Periodontol. 2018 Jun;45 Suppl 20:S237-S245
pubmed: 29926488
J Periodontol. 2014 Jan;85(1):204-10
pubmed: 23659423
Arch Immunol Ther Exp (Warsz). 2006 Nov-Dec;54(6):419-26
pubmed: 17122880
J Periodontol. 2018 Jan;89(1):117-129
pubmed: 28846062
Clin Oral Implants Res. 2017 Feb;28(2):129-136
pubmed: 26799246
J Prosthodont Res. 2012 Oct;56(4):249-55
pubmed: 23083963
Int J Dent. 2013;2013:740680
pubmed: 23983691
J Clin Periodontol. 2018 Jun;45 Suppl 20:S246-S266
pubmed: 29926484
Clin Oral Investig. 2013 Jan;17(1):311-6
pubmed: 22382449
Dent Clin North Am. 1986 Jan;30(1):151-74
pubmed: 3514290
J Clin Periodontol. 2015 Apr;42 Suppl 16:S158-71
pubmed: 25495683
J Clin Periodontol. 2010 Feb;37(2):180-90
pubmed: 19995403
Mol Oral Microbiol. 2017 Aug;32(4):275-287
pubmed: 27448788
J Immunol. 2000 May 15;164(10):4991-5
pubmed: 10799849
Int J Oral Implantol (Berl). 2020;13(2):123-139
pubmed: 32424380
J Clin Periodontol. 2011 Mar;38 Suppl 11:188-202
pubmed: 21323715
Cells. 2020 May 25;9(5):
pubmed: 32466129
J Immunol. 2007 Sep 15;179(6):4065-73
pubmed: 17785845
J Immunol. 2015 Feb 15;194(4):1417-21
pubmed: 25595774
Nat Rev Microbiol. 2007 Apr;5(4):264-77
pubmed: 17363965
J Periodontol. 2015 Jun;86(6):746-54
pubmed: 25741580
J Periodontal Res. 2019 Dec;54(6):720-728
pubmed: 31321776
Periodontol 2000. 2016 Feb;70(1):142-63
pubmed: 26662488
Expert Rev Clin Immunol. 2017 Dec;13(12):1189-1197
pubmed: 29027827
Clin Oral Implants Res. 2016 Feb;27(2):211-7
pubmed: 25682848
Clin Implant Dent Relat Res. 2018 Dec;20(6):962-968
pubmed: 30370993
J Periodontol. 2018 Jun;89 Suppl 1:S313-S318
pubmed: 29926955
J Clin Periodontol. 2008 Sep;35(8 Suppl):282-5
pubmed: 18724855
Implant Dent. 2019 Feb;28(1):4-10
pubmed: 30363048
Periodontol 2000. 2020 Oct;84(1):145-160
pubmed: 32844418
J Clin Med. 2019 Oct 01;8(10):
pubmed: 31581596
Clin Oral Implants Res. 2017 Sep;28(9):1127-1132
pubmed: 27422156
Clin Oral Investig. 2020 May;24(5):1837-1844
pubmed: 31444693
JDR Clin Trans Res. 2019 Oct;4(4):352-359
pubmed: 31013451
J Periodontol. 2009 Feb;80(2):234-43
pubmed: 19186963
Odontology. 2021 Apr;109(2):540-546
pubmed: 33185753
Oral Dis. 2018 Nov;24(8):1562-1571
pubmed: 29969841
J Clin Periodontol. 2020 Sep;47(9):1064-1078
pubmed: 32602969
Int J Chronic Dis. 2014;2014:363581
pubmed: 26464855
J Clin Periodontol. 2012 Dec;39(12):1141-8
pubmed: 23067264
J Immunol. 2003 Apr 1;170(7):3812-8
pubmed: 12646648
Cytokine. 2021 Jul;143:155506
pubmed: 33846070
Diagnostics (Basel). 2017 Jan 20;7(1):
pubmed: 28117682
Head Face Med. 2014 Sep 03;10:34
pubmed: 25185675
J Dent Res. 2013 Feb;92(2):161-5
pubmed: 23242230
Innate Immun. 2010 Jun;16(3):168-74
pubmed: 20418257
Mucosal Immunol. 2017 Jul;10(4):1021-1030
pubmed: 27966555
J Clin Periodontol. 2021 Apr;48(4):590-601
pubmed: 33454996
Clin Oral Implants Res. 2018 Oct;29 Suppl 16:331-350
pubmed: 30328195
Diagn Microbiol Infect Dis. 2017 May;88(1):47-52
pubmed: 28274501
J Clin Periodontol. 2020 Mar;47(3):289-308
pubmed: 31701554
J Clin Periodontol. 2004 May;31(5):341-7
pubmed: 15086615
J Periodontal Res. 2018 Feb;53(1):107-116
pubmed: 29044525

Auteurs

Glaucia Schuindt Teixeira Neves (GS)

Department of Prosthodontics, School of Dentistry, Rio de Janeiro State University, Rio de Janeiro 20551-030, Brazil.
Department of Endodontics, School of Dentistry, University of Texas, Houston, TX 77054, USA.

Gayathiri Elangovan (G)

School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland 4222, Australia.

Mayla Kezy Silva Teixeira (MKS)

Department of Prosthodontics, School of Dentistry, Rio de Janeiro State University, Rio de Janeiro 20551-030, Brazil.

João Martins de Mello-Neto (JM)

School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland 4222, Australia.

Santosh Kumar Tadakamadla (SK)

School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland 4222, Australia.
Menzies Health Institute Queensland, Queensland 4222, Australia.

Eduardo José Veras Lourenço (EJV)

Department of Prosthodontics, School of Dentistry, Rio de Janeiro State University, Rio de Janeiro 20551-030, Brazil.

Daniel Moraes Telles (DM)

Department of Prosthodontics, School of Dentistry, Rio de Janeiro State University, Rio de Janeiro 20551-030, Brazil.

Carlos Marcelo Figueredo (CM)

School of Medicine and Dentistry, Griffith University, Gold Coast, Queensland 4222, Australia.
Department of Periodontology, School of Dentistry, Rio de Janeiro State University, Rio de Janeiro 20551-030, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH